LON:HLN Haleon - HLN Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 328.85 +5.10 (+1.58%) (As of 03/22/2023 04:45 PM ET) Add Compare Share Share Today's Range 324.20▼ 330.7050-Day Range 310.10▼ 33652-Week Range 241.17▼ 337.95Volume12.24 million shsAverage Volume13.67 million shsMarket Capitalization£30.35 billionP/E Ratio2,989.55Dividend Yield1.52%Price TargetGBX 331.56 ProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlines Haleon MarketRank™ ForecastAnalyst RatingHold2.22 Rating ScoreUpside/Downside1.8% DownsideGBX 323.09 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.95 out of 5 stars 1.1 Analyst's Opinion Consensus RatingHaleon has received a consensus rating of Hold. The company's average rating score is 2.22, and is based on 3 buy ratings, 5 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 323.09, Haleon has a forecasted downside of 1.8% from its current price of GBX 328.85.Amount of Analyst CoverageHaleon has only been the subject of 4 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for HLN. Previous Next 0.8 Dividend Strength Dividend YieldHaleon pays a meaningful dividend of 1.49%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 4,545.45%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLN. Previous Next 1.8 News and Social Media Coverage News SentimentHaleon has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.34 average news sentiment score of Medical companies.Search Interest51 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 24% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have not sold or bought any company stock.Percentage Held by Insiders38.55% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 25.39% of the stock of Haleon is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 2,989.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 119.65.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 2,989.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 90.56.Price to Earnings Growth RatioHaleon has a PEG Ratio of 2.52. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Haleon (LON:HLN) StockHaleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.Read More Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address HLN Stock News HeadlinesMarch 5, 2023 | msn.comUK stocks to buy amid a cost-of-living crisis!March 5, 2023 | finance.yahoo.comHaleon plc Just Missed Earnings - But Analysts Have Updated Their ModelsMarch 22, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastMarch 2, 2023 | finance.yahoo.comHaleon PLC Announces Redemption of US$300,000,000 Outstanding NotesFebruary 22, 2023 | msn.comThese 3 top banks think the Haleon share price will rally. What should I do?February 8, 2023 | reuters.comHLN.L - | Stock Price & Latest News | ReutersFebruary 1, 2023 | reuters.comAnalysis: GSK gives few clues on plans to replenish medicine cabinetFebruary 1, 2023 | proactiveinvestors.comHaleon's reported strategic M&A dismissed as 'highly unlikely' and unwanted headacheMarch 22, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastJanuary 31, 2023 | seekingalpha.comHaleon: A Great Consumer Staples AddJanuary 20, 2023 | seekingalpha.comSuccessful Data Analysis Could Be Game Changer For HaleonDecember 24, 2022 | finance.yahoo.comHaleon plc (LON:HLN) Delivered A Weaker ROE Than Its IndustryDecember 13, 2022 | msn.comThe Haleon share price is back near where it started. Should I buy the stock now?December 7, 2022 | proactiveinvestors.comHaleon upgraded by Barclays after Zantac litigation dismissedDecember 6, 2022 | seekingalpha.comWhy did Sanofi stock Jump up today? Zantac litigation tossed out by judgeDecember 6, 2022 | finance.yahoo.comShould You Add Haleon plc (HLN) to Your Portfolio?December 2, 2022 | finance.yahoo.comIs Haleon plc (HLN) a Good Investment Avenue?November 30, 2022 | seekingalpha.comTracking Kahn Brothers Portfolio - Q3 2022 UpdateNovember 26, 2022 | seekingalpha.comHaleon's Dilemma: To Wait Or Not To WaitNovember 11, 2022 | finance.yahoo.comHere’s What Makes Haleon (HLN) an Attractive Investment PickNovember 10, 2022 | msn.comHaleon hits 3-month high after raising full-year profit outlookNovember 10, 2022 | msn.comFormer GSK consumer health arm Haleon posts 16.1% jump in quarterly salesNovember 10, 2022 | proactiveinvestors.comHaleon hikes organic revenue guidance after sustained price increasesNovember 2, 2022 | proactiveinvestors.comHaleon third-quarter update is big date for Pfizer stock overhangOctober 31, 2022 | finance.yahoo.comHaleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSKOctober 11, 2022 | proactiveinvestors.comBarclays analysts impressed by Haleon sales targetsSeptember 29, 2022 | finance.yahoo.comHaleon plc Announces Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSKSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address HLN Company Calendar Ex-Dividend for 4/27 Dividend3/16/2023Today3/22/2023Dividend Payable4/27/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolLON:HLN CUSIPN/A CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 323.09 High Stock Price ForecastGBX 376 Low Stock Price ForecastGBX 250 Forecasted Upside/Downside+1.3%Consensus RatingHold Rating Score (0-4)2.22 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.11 Trailing P/E Ratio2,975.45 Forward P/E Ratio18.21 P/E Growth2.52Net Income£1.06 billion Net Margins9.76% Pretax MarginN/A Return on Equity5.21% Return on Assets4.30% Debt Debt-to-Equity Ratio64.50 Current Ratio0.93 Quick Ratio0.93 Sales & Book Value Annual Sales£10.86 billion Price / Sales2.78 Cash FlowGBX 14.91 per share Price / Cash Flow21.95 Book ValueGBX 177 per share Price / Book1.85Miscellaneous Outstanding Shares9,230,000,000Free FloatN/AMarket Cap£30.21 billion OptionableNot Optionable BetaN/A Key ExecutivesMr. Brian McNamara (Age 56)CEO & Exec. Director Mr. Tobias Hestler (Age 51)CFO & Exec. Director Ms. Amy LanducciHead of Digital and TechnologyMr. Bjarne Philip Tellmann (Age 56)Gen. Counsel Ms. Tamara Rogers (Age 54)Chief Marketing Officer Ms. Mairead Nayager (Age 48)Chief HR Officer Mr. Bart Derde (Age 54)Head of Quality and Supply Chain Mr. Filippo LanziHead of EMEA & LatAmMs. Teri Lyng (Age 61)Head of Transformation & Sustainability Ms. Jooyong Lee (Age 46)Head of Strategy and Office of the CEO More ExecutivesKey CompetitorsSmith & NephewLON:SNGSKLON:GSKHikma PharmaceuticalsLON:HIKAmryt PharmaLON:AMYTBenchmarkLON:BMKView All CompetitorsInsidersJohn YoungBought 80,541 shares on 8/2/2022Total: £25.13 M ($312.00/share)Dave LewisBought 63,151 shares on 7/27/2022Total: £20.02 M ($317.00/share)View All Insider Transactions HLN Stock - Frequently Asked Questions Should I buy or sell Haleon stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares. View HLN analyst ratings or view top-rated stocks. What is Haleon's stock price forecast for 2023? 9 analysts have issued twelve-month target prices for Haleon's stock. Their HLN share price forecasts range from GBX 250 to GBX 376. On average, they anticipate the company's share price to reach GBX 323.09 in the next twelve months. This suggests that the stock has a possible downside of 1.3%. View analysts price targets for HLN or view top-rated stocks among Wall Street analysts. How have HLN shares performed in 2023? Haleon's stock was trading at GBX 327.35 at the beginning of the year. Since then, HLN stock has decreased by 0.0% and is now trading at GBX 327.30. View the best growth stocks for 2023 here. How often does Haleon pay dividends? What is the dividend yield for Haleon? Haleon announced a dividend on Thursday, March 2nd. Stockholders of record on Thursday, March 16th will be given a dividend of GBX 2.40 per share on Thursday, April 27th. This represents a yield of 0.74%. The ex-dividend date is Thursday, March 16th. The official announcement can be seen at this link. Read our dividend analysis for HLN. Is Haleon a good dividend stock? Haleon (LON:HLN) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 1.49%. The dividend payout ratio is 4,545.45%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for HLN. What is Haleon's stock symbol? Haleon trades on the London Stock Exchange (LON) under the ticker symbol "HLN." How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Haleon's stock price today? One share of HLN stock can currently be purchased for approximately GBX 327.30. How much money does Haleon make? Haleon (LON:HLN) has a market capitalization of £30.21 billion and generates £10.86 billion in revenue each year. The company earns £1.06 billion in net income (profit) each year or GBX 0.11 on an earnings per share basis. How can I contact Haleon? The official website for the company is www.haleon.com. The company can be reached via phone at 44 1932 822000. This page (LON:HLN) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.